Sign in or create an account to add this stock to your watchlist.
About Given Imaging (NASDAQ:GIVN)
Given Imaging Ltd (Given) develops, manufactures and markets diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. It is engaged in capsule endoscopy, which is an approach to visual examination of the gastrointestinal tract through the use of a miniaturized video camera contained in an ingestible disposable capsule. Its principal product, which incorporates its core technology, is the Given System, a wireless imaging system that uses its disposable video capsules, the PillCam capsules. The PillCam capsules can be easily ingested by patients and move naturally through the gastrointestinal tract while wirelessly transmitting to a portable recorder, enabling the gastroenterologist to view video, images and data on a computer workstation, utilizing its RAPID software. In October 2012, it acquired the assets related to the SmartPill GI Monitoring System from The SmartPill Corporation.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Given Imaging (NASDAQ:GIVN) Frequently Asked Questions
What is Given Imaging's stock symbol?
Given Imaging trades on the NASDAQ under the ticker symbol "GIVN."
Who are Given Imaging's key executives?
Given Imaging's management team includes the folowing people:
- Israel Makov, Chairman of the Board (Age 76)
- Nachum Shamir, President, Chief Executive Officer, Director (Age 62)
- Yuval Yanai, Chief Financial Officer (Age 64)
- Skip Baldino, President, Americas (Age 53)
- Thomas Pracht, President, EMEA (Age 56)
- Kazem Samandari, President, Asia Pacific/Japan (Age 62)
- Thomas Looby, Senior Vice President, Chief Marketing Officer (Age 44)
- Ido Warshavski, Senior Vice President, General Counsel, Corporate Secretary (Age 44)
- Keith A. Chrzanowski, Senior Vice President - Global Human Resources (Age 52)
- Ori J Braun, Senior Vice President - Business Development (Age 57)
Has Given Imaging been receiving favorable news coverage?
News coverage about GIVN stock has trended positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Given Imaging earned a news sentiment score of 0.27 on Accern's scale. They also assigned media headlines about the healthcare company an impact score of 47.38 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Given Imaging?
Shares of GIVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How big of a company is Given Imaging?
Given Imaging has a market capitalization of $988.92 million.
How can I contact Given Imaging?
Given Imaging's mailing address is Hermon Building, New Industrial Park, YOKNEAM, 2066724, Israel. The healthcare company can be reached via phone at +972-4-9097777.
MarketBeat Community Rating for Given Imaging (GIVN)MarketBeat's community ratings are surveys of what our community members think about Given Imaging and other stocks. Vote "Outperform" if you believe GIVN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GIVN will underperform the S&P 500 over the long term. You may vote once every thirty days.
Given Imaging (NASDAQ:GIVN) Analyst Ratings History
(Data available from 5/27/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Given Imaging (NASDAQ:GIVN) Earnings History and Estimates Chart
Given Imaging (NASDAQ GIVN) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/5/2013||Q3 2013||$0.19||$0.21||$48.80 million||$50.02 million||View||N/A|
|8/6/2013||Q213||$0.18||$0.22||$48.23 million||$49.50 million||View||N/A|
|5/8/2013||Q113||$0.13||$0.06||$44.63 million||$40.60 million||View||N/A|
|2/12/2013||Q412||$0.30||$0.25||$52.93 million||$48.70 million||View||N/A|
|11/6/2012||Q312||$0.22||$0.25||$47.36 million||$45.40 million||View||N/A|
Given Imaging (NASDAQ:GIVN) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Given Imaging (NASDAQ GIVN) Insider Trading and Institutional Ownership History
Given Imaging (NASDAQ GIVN) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Given Imaging (NASDAQ GIVN) News Headlines
Given Imaging (NASDAQ:GIVN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Given Imaging (NASDAQ:GIVN) Income Statement, Balance Sheet and Cash Flow Statement
Given Imaging (NASDAQ GIVN) Stock Chart for Sunday, May, 27, 2018